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Objectives
The large number of scales and items within generic
and disease specific HRQL measures may lead to out-
come reporting bias of HRQL data. We explored this
hypothesis in publications of HRQL results from studies
of curative treatment for oesophageal cancer.
Methods
Systematic literature searches (MEDLINE, Embase, Psy-
cINFO and CINAHL) identified articles reporting
HRQL data after curative treatments for oesophageal
cancer from validated patient-completed questionnaires.
The most frequently used instruments were examined
(EORTC QLQ-C30, QLQ-OES24, QLQ-OES18, SF-36 &
FACT-E). Outcome reporting bias was explored by
examining which of the instrument’s scales and single
items were documented in the methods and the results
of papers, with each article checked by two independent
reviewers.
Results
Of 52 included papers, three specified to focus on a
restricted set of the measured scales in the study meth-
o d s ,w i t ho n ep r o v i d i n gar a t i o n a l ef o rd o i n gs o .3 1
p a p e r s( 6 0 % )r e p o r t e dE O R T CQ L Q - C 3 0r e s u l t s ,o f
which 20 (65%) reported all 15 of the instrument’s scales
and single items. Global health status was consistently
reported (30/31 papers, 97%), followed by physical func-
tion (29/31, 94%) and role function (28/31, 90%). Insom-
nia and constipation were least reported (22/31, 71%).
25 papers additionally included the QLQ-OES24 or
QLQ-OES18 oesophageal-specific module (consisting of
11 and 10 scales and single items respectively). All of
the module scales and items were reported in 14/25
papers (56%). Dysphagia, eating and reflux scales were
most often reported (in 24, 23, and 22 papers respec-
tively). 12 papers reported SF-36 results, of which 9
(75%) reported all 8 scales. SF-36 physical functioning,
role-physical, role-emotional, social functioning, vitality
and general health scales were reported most often (11/
12 papers), followed by bodily pain and mental health
(10/12 papers). Three studies used the FACT-E, and all
reported the 5 subscales (physical well-being, functional
well-being, social/family well-being, emotional well-
being and the oesophageal cancer subscale).
Conclusions
Selective outcome reporting was evident in some studies
of curative treatment for oesophageal cancer, increas-
ingly when a higher number of scales and items were
available. The development of a core outcome set of
HRQL domains for RCTs of curative treatments in
oesophageal cancer may reduce the risk of outcome
reporting bias and ensure important domains are consis-
tently reported.
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